메뉴 건너뛰기




Volumn 14, Issue 6, 2001, Pages 729-734

Can GnRH-agonist treatment cause slipped capital femoral epiphysis?

Author keywords

Central precocious puberty; GnRH agonists; Slipped capital femoral epiphysis

Indexed keywords

BUSERELIN; CYPROTERONE ACETATE; GONADORELIN AGONIST; MEDROXYPROGESTERONE; TRIPTORELIN;

EID: 0034948767     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2001.14.6.729     Document Type: Article
Times cited : (12)

References (28)
  • 1
    • 0001806269 scopus 로고
    • The endocrine basis for slipping of the upper femoral epiphysis: An experimental study
    • (1950) J Bone Joint Surg , vol.32 B , pp. 5-11
    • Harris, W.R.1
  • 4
    • 0022589872 scopus 로고
    • Growth and pubertal development in slipped capital femoral epiphysis: A longitudinal study
    • (1986) J Pediatr Orthop , vol.6 , pp. 403-409
    • Exner, G.U.1
  • 13
    • 0015893979 scopus 로고
    • Epidemiology of slipped capital femoral epiphysis: A review of the literature
    • (1973) Pediatrics , vol.51 , pp. 1042-1050
    • Kelsey, J.L.1
  • 21
  • 22
    • 0004649101 scopus 로고    scopus 로고
    • Incidence of slipped capital femoral epiphysis in growth hormone treated children
    • Experience from KIGS, the Pharmacia & Upjohn International Growth Database.
    • (1996) Horm Res , vol.46 , Issue.SUPPL. 2 , pp. 53
    • Wilton, P.1    Oden, A.2
  • 26
    • 29444450289 scopus 로고
    • Tables for predicting adult height from skeletal age: Revised for use with the Greulich and Pyle hand standard
    • (1952) J Pediatr , vol.40 , pp. 423-444
    • Bayley, N.1    Pinneau, S.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.